Advertisement
During the webcast, Bruce Barrett, Somanetics' president and chiefexecutive officer, and Bill Iacona, chief financial officer, will reviewcorporate highlights and summarize Somanetics' financial results for the threeand nine months ended August 31, 2007.
Advertisement
To listen to the webcast, visit the Investor Center page of Somanetics'website, http://www.somanetics.com , 15 minutes prior to the event's broadcastand click on the link titled "Q3 2007 Somanetics Corporation EarningsConference Call." Interested parties unable to listen to the live call mayaccess the archived version of the call on the Investor Center page ofSomanetics' website for one year after the call. Windows Media Player isrequired for access to the webcast, and is available for downloading free ofcharge on the webcast page.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and marketsthe INVOS(R) Cerebral/Somatic Oximeter System, a non-invasive patientmonitoring system that continuously measures changes in the blood oxygenlevels in the brain and elsewhere in the body in somatic, or skeletal muscle,tissue in patients with or at risk for restricted blood flow. Surgeons,anesthesiologists and other medical professionals can use the informationprovided by the INVOS System, in conjunction with other available information,to identify brain oxygen imbalances and take necessary corrective action,potentially improving patient outcomes and reducing the costs of care.Somanetics supports its customers through a direct U.S. sales force andclinical education team. Tyco Healthcare markets INVOS System products inEurope, Canada, the Middle East and Africa and Edwards Lifesciences representsINVOS System products in Japan. For more information visitwww.somanetics.com.
SOURCE Somanetics Corporation
